Filing Flows › Elanco Animal Health (ELAN) › Guidance history
Elanco Animal Health (ELAN) guidance history: what it guided and what it reported
Elanco Animal Health gave guidance in 13 earnings releases on file since Feb 26, 2024. Of 2 guided periods since reported, it met or beat its own guidance twice (100%). Revenue: 2 of 2, on average +1.9% against the guided midpoint. Its releases raised guidance 10 times and lowered it 5 times.
Revenue
Met or beat 2 of 2 periods (1 above, 1 within, 0 below).
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $5.0B–$5.0B (Feb 24, 2026) → raised $5.0B–$5.1B (May 6, 2026) → raised $5.1B–$5.1B (Aug 5, 2026) → raised $5.2B–$5.2B (Nov 6, 2026) | — | to be reported | — |
| FY2025 | $4.4B–$4.5B (Feb 25, 2025) → raised $4.5B–$4.6B (May 7, 2025) | $4.7B | above the range | +3.7% |
| FY2024 | $4.5B–$4.5B (Feb 26, 2024) → reaffirmed $4.5B–$4.5B (May 8, 2024) → lowered $4.4B–$4.5B (Aug 8, 2024) → reaffirmed $4.4B–$4.5B (Nov 7, 2024) | $4.4B | within the range | +0.1% |
| Q4 2024 | $1.0B–$1.0B (Nov 7, 2024) | — | — | — |
| Q3 2024 | $1.0B–$1.1B (Aug 8, 2024) | — | — | — |
| Q2 2024 | $1.1B–$1.2B (May 8, 2024) | — | — | — |
| Q1 2024 | $1.2B–$1.2B (Feb 26, 2024) | — | — | — |
Adjusted gross margin
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | 55.1%–55.5% (May 6, 2026) → reaffirmed 55.2%–55.6% (Aug 5, 2026) → raised 55.8%–56.0% (Nov 6, 2026) | — | to be reported | — |
| FY2025 | 54.2%–54.7% (May 7, 2025) → raised 54.5%–55.0% (Aug 7, 2025) → raised 54.9%–55.2% (Nov 5, 2025) | — | — | — |
Tax rate
This line is not in the statements Filing Flows reads, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | 22.8% (Nov 6, 2026) | — | to be reported | — |
| FY2025 | 21.0%–22.0% (Feb 25, 2025) | — | — | — |
Interest expense
This line is not in the statements Filing Flows reads, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2024 | $65.0M (Feb 26, 2024) → reaffirmed $65.0M (May 8, 2024) | — | — | — |
GAAP EPS
This line is not in the statements Filing Flows reads, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2025 | −$0.07–−$0.01 (May 7, 2025) → lowered −$0.08–−$0.03 (Aug 7, 2025) → raised $0.08–$0.11 (Nov 5, 2025) | — | — | — |
Free cash flow
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $1.3B–$1.3B (Feb 24, 2026) | — | to be reported | — |
The latest quarter
Elanco Animal Health, Q3 2026: revenue $1.3B (+11% year over year), operating margin 1.9%, net earnings $18.0M, operating cash flow $216M. The chart follows the revenue to costs, profit and cash.
Questions
Does Elanco Animal Health beat its guidance?
Elanco Animal Health gave guidance in 13 earnings releases on file since Feb 26, 2024. Of 2 guided periods since reported, it met or beat its own guidance twice (100%). Revenue: 2 of 2, on average +1.9% against the guided midpoint.
How often does Elanco Animal Health raise guidance?
Its earnings releases raised guidance 10 times and lowered it 5 times since Feb 26, 2024.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.